Amalgamated Bank Bridge Bio Pharma, Inc. Transaction History

Amalgamated Bank

$12.6 Billion
Q2 2025

A detailed history of Amalgamated Bank transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 4,880 shares of BBIO stock, worth $227,310. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,880

Previous 4,880 -0.0%

Holding current value

$227,310

Previous $169,000 24.26%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$28.12 - $37.59 $478 - $639	17 Added 0.35%	4,880 $169,000
Q2 2024 Aug 12, 2024	BUY	$23.0 - $31.04 $22,126 - $29,860	962 Added 24.66%	4,863 $123,000
Q1 2024 Apr 23, 2024	SELL	$27.35 - $40.45 $287,913 - $425,817	-10,527 Reduced 72.96%	3,901 $121,000
Q4 2023 Feb 06, 2024	SELL	$24.02 - $43.89 $32,354 - $59,119	-1,347 Reduced 8.54%	14,428 $582,000
Q3 2023 Nov 08, 2023	BUY	$16.89 - $35.01 $9,728 - $20,165	576 Added 3.79%	15,775 $416,000
Q2 2023 Aug 11, 2023	BUY	$13.29 - $18.01 $25,264 - $34,237	1,901 Added 14.3%	15,199 $261,000
Q1 2023 May 02, 2023	SELL	$7.17 - $18.55 $15,616 - $40,401	-2,178 Reduced 14.07%	13,298 $220,000
Q3 2022 Nov 09, 2022	BUY	$7.94 - $12.36 $1,310 - $2,039	165 Added 1.08%	15,476 $154,000
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $2,516 - $5,863	-483 Reduced 3.06%	15,311 $139,000
Q1 2022 Jun 30, 2022	SELL	$7.34 - $17.16 $10,261 - $23,989	-1,398 Reduced 8.13%	15,794 $160,000
Q4 2021 Feb 15, 2022	SELL	$11.38 - $53.41 $3,243 - $15,221	-285 Reduced 1.63%	17,192 $287,000
Q3 2021 Oct 29, 2021	SELL	$46.87 - $64.24 $53,103 - $72,783	-1,133 Reduced 6.09%	17,477 $819,000
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $242,433 - $333,522	5,217 Added 38.95%	18,610 $1.13 Million
Q1 2021 May 13, 2021	BUY	$55.47 - $72.35 $111,550 - $145,495	2,011 Added 17.67%	13,393 $825,000
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $2,187 - $4,053	57 Added 0.5%	11,382 $809,000
Q3 2020 Oct 30, 2020	SELL	$27.2 - $42.19 $9,057 - $14,049	-333 Reduced 2.86%	11,325 $425,000
Q2 2020 Aug 10, 2020	SELL	$22.22 - $35.69 $30,685 - $49,287	-1,381 Reduced 10.59%	11,658 $380,000
Q1 2020 May 13, 2020	BUY	$16.11 - $36.23 $210,058 - $472,402	13,039 New	13,039 $378,000

Others Institutions Holding BBIO

# of Institutions

387

Shares Held

184M

Call Options Held

12.8M

Put Options Held

2.28M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $6.91B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Bridge Bio Pharma, Inc. Transaction History